feed,title,long_url,short_url
Benzinga,Trial Setback For Gilead Sciences: Shuts Late-Stage Magrolimab/Azacitidine Combo Study In Type Of Blood Cancer,https://benzinga.com/general/biotech/23/07/33341414/trial-setback-for-gilead-sciences-shuts-late-stage-magrolimabazacitidine-combo-study-in-type-of-b,https://da.gd/w0XX
